These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 3685460)

  • 1. Chemical toxicity, cytochrome P-450, and computer graphics.
    Parke DV
    Regul Toxicol Pharmacol; 1987 Sep; 7(3):220-1. PubMed ID: 3685460
    [No Abstract]   [Full Text] [Related]  

  • 2. Metabolic activation of carcinogens and toxic chemicals.
    Parke DV; Ioannides C; Lewis DF
    Hum Toxicol; 1988 Sep; 7(5):397-404. PubMed ID: 3192223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of cytochrome P4501 as an indicator of potential chemical carcinogenesis.
    Ioannides C; Parke DV
    Drug Metab Rev; 1993; 25(4):485-501. PubMed ID: 8313839
    [No Abstract]   [Full Text] [Related]  

  • 4. Activation of procarcinogens by human cytochrome P450 enzymes.
    Guengerich FP; Shimada T
    Mutat Res; 1998 May; 400(1-2):201-13. PubMed ID: 9685642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible similar role of cytochrome P450 in primordial evolution of species and in chemical carcinogenesis.
    Wickramasinghe RH; Villee CA
    Perspect Biol Med; 1976; 19(4):473-5. PubMed ID: 958862
    [No Abstract]   [Full Text] [Related]  

  • 6. The cytochromes P-448--a unique family of enzymes involved in chemical toxicity and carcinogenesis.
    Ioannides C; Parke DV
    Biochem Pharmacol; 1987 Dec; 36(24):4197-207. PubMed ID: 3318843
    [No Abstract]   [Full Text] [Related]  

  • 7. Protection against chemical-induced lung injury by inhibition of pulmonary cytochrome P-450.
    Verschoyle RD; Dinsdale D
    Environ Health Perspect; 1990 Apr; 85():95-100. PubMed ID: 2384072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Developments and perspectives on the role of cytochrome P450s in chemical carcinogenesis.
    Miles JS; Wolf CR
    Carcinogenesis; 1991 Dec; 12(12):2195-9. PubMed ID: 1747917
    [No Abstract]   [Full Text] [Related]  

  • 9. Validation of a novel molecular orbital approach (COMPACT) for the prospective safety evaluation of chemicals, by comparison with rodent carcinogenicity and Salmonella mutagenicity data evaluated by the U.S. NCI/NTP.
    Lewis DF; Ioannides C; Parke DV
    Mutat Res; 1993 Feb; 291(1):61-77. PubMed ID: 7678916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of cytochromes P-450 in mouse liver tumor production.
    Parke DV; Ioannides C
    Prog Clin Biol Res; 1990; 331():215-30. PubMed ID: 2179958
    [No Abstract]   [Full Text] [Related]  

  • 11. Cytochrome P-450 enzymes as targets for chemoprevention against chemical carcinogenesis and toxicity: opportunities and limitations.
    Yang CS; Smith TJ; Hong JY
    Cancer Res; 1994 Apr; 54(7 Suppl):1982s-1986s. PubMed ID: 8137324
    [No Abstract]   [Full Text] [Related]  

  • 12. Cytochromes P450 in the bioactivation of chemicals.
    Ioannides C; Lewis DF
    Curr Top Med Chem; 2004; 4(16):1767-88. PubMed ID: 15579107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytochrome P450. Mechanisms of action and clinical implications.
    Williams MT
    J Fla Med Assoc; 1992 Jun; 79(6):405-8. PubMed ID: 1640215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The active site of cytochrome P-450 nifedipine oxidase: a model-building study.
    Ferenczy GG; Morris GM
    J Mol Graph; 1989 Dec; 7(4):206-11. PubMed ID: 2486822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3D molecular graphics on the World Wide Web.
    Vollhardt H; Brickmann J
    Pac Symp Biocomput; 1996; ():663-73. PubMed ID: 9390266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computer modelling in predicting carcinogenicity.
    Ioannides C; Lewis DF; Parke DV
    Eur J Cancer Prev; 1993 May; 2(3):275-82. PubMed ID: 8490550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genoprotection by UDP-glucuronosyltransferases in peroxidase-dependent, reactive oxygen species-mediated micronucleus initiation by the carcinogens 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and benzo[a]pyrene.
    Kim PM; Wells PG
    Cancer Res; 1996 Apr; 56(7):1526-32. PubMed ID: 8603397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Active site model of cytochrome P-450 LM2.
    Schwarze W; Jaeger J; Jänig GR; Ruckpaul K
    Biochem Biophys Res Commun; 1988 Feb; 150(3):996-1005. PubMed ID: 3342074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the nature of non-genotoxic carcinogens. A unified theory including NGCs, co-carcinogens and promoters.
    Paolini M; Biagi GL; Bauer C; Cantelli-Forti G
    Mutat Res; 1992 Apr; 281(4):245-6. PubMed ID: 1373217
    [No Abstract]   [Full Text] [Related]  

  • 20. Adverse reactions of imidazole antifungal agents: computer graphic studies of cytochrome P-450 interactions.
    Lewis DF; Rodrigues AD; Ioannides C; Parke DV
    J Biochem Toxicol; 1989; 4(4):231-4. PubMed ID: 2634093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.